EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 28.26
+0.26 (0.93%)
Aug 14, 2025, 3:15 PM GMT+1
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 125.75 million as of August 14, 2025. Its market cap has decreased by -0.13% in one year.
Market Cap
125.75M
Enterprise Value
114.94M
Revenue
50.19M
Ranking
n/a
PE Ratio
20.35
Stock Price
28.26
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 125.75M, an increase of 5,430.91%. That is a compound annual growth rate of 19.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 125.75M | 2.64% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | 326.46M | 109.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.82B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 4.01B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 2.02B |